Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 17/20 | 0.45 |
| ▸ | BACE2 | Q9Y5Z0 | 5/20 | 0.45 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
| ▸ | CTSD | P07339 | 3/20 | 0.42 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8361174 | 0.86 | BACE1 (0.46) | BACE1BACE2CTSDNTRK2 | |
| SCHEMBL8320359 | 0.80 | NTRK2 (0.51) | BACE1BACE2F2NTRK2 | |
| SCHEMBL8322037 | 0.78 | BACE1 (0.39) | BACE1BACE2F2CTSDNTRK2 | |
| SCHEMBL8322069 | 0.77 | BACE1 (0.44) | BACE1BACE2CTSD | |
| SCHEMBL13930094 | 0.76 | BACE1 (0.60) | BACE1 | |
| SCHEMBL5579146 | 0.74 | BACE1 (0.69) | BACE1BACE2CTSD | |
| SCHEMBL5367552 | 0.74 | BACE1 (0.69) | BACE1BACE2CTSD | |
| SCHEMBL5633480 | 0.74 | BACE1 (0.69) | BACE1BACE2CTSD | |
| SCHEMBL2961346 | 0.74 | BACE1 (0.57) | BACE1BACE2CTSD | |
| SCHEMBL14141210 | 0.73 | TP53 (0.50) | BACE1BACE2F2CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004058686-A1 | HYDROXYPROPYL AMIDES FOR THE TREATMENT OF ALZHEIMER’S DISEASE | ELAN PHARMACEUTICALS, INC. (US) | 2004-07-15 | — | — | WO | disclosed |